Jan 10, 2023
A new FDA-approved Alzheimer’s medicine slowed cognitive decline in patients
Posted by Gemechu Taye in categories: biotech/medical, neuroscience
Naeblys/iStock.
Also known as lecanemab, Leqembi is the second drug of its kind – a medication that has been approved for treating Alzheimer’s disease. This type of medication targets the fundamental pathophysiology of the disease and is considered a significant development in the effort to successfully treat Alzheimer’s disease.